An Open-Label Crossover Study To Evaluate Potential Pharmacokinetic Interactions between Oral Oseltamivir and Intravenous Zanamivir in Healthy Thai Adults

There is no parenteral formulation of the neuraminidase inhibitor oseltamivir, the most widely used anti-influenza virus drug. Oseltamivir resistance is an increasing problem. Zanamivir is effective against the most prevalent oseltamivir-resistant influenza viruses. A parenteral formulation of zanam...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Pukrittayakamee, Sasithon, Jittamala, Podjanee, Stepniewska, Kasia, Lindegardh, Niklas, Chueasuwanchai, Sunee, Leowattana, Wattana, Phakdeeraj, Aphiradee, Permpunpanich, Sutatip, Hanpithakpong, Warunee, Pan-Ngum, Wirichada, Fukuda, Caroline, Panapipat, Salwaluk, Singhasivanon, Pratap, White, Nicholas J., Day, Nicholas P. J.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2011
Assuntos:
Antiviral Agents
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3165358/
https://ncbi.nlm.nih.gov/pubmed/21690287
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00159-11
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados